Pallasite Ventures

Aspect Biosystems Ltd. is a biotechnology company based in Vancouver, Canada, specializing in 3D bioprinting and tissue engineering. Founded in 2013, the company leverages proprietary microfluidic 3D bioprinting technology to develop bioprinted tissue therapeutics aimed at transforming disease treatment. By integrating therapeutic cells and materials science, Aspect Biosystems creates allogeneic cell-based tissue therapeutics that can replace or repair damaged organ functions. The company also provides a Lab-on-a-printer technology that allows precise control over biomaterial composition and structure during tissue fabrication. Its innovative platform supports the development of novel therapeutics and enhances understanding in fundamental biology and disease research, catering to pharmaceutical firms and academic institutions focused on respiratory diseases and regenerative medicine. Aspect Biosystems is actively collaborating with researchers and industry leaders to address significant challenges in the field of regenerative medicine.

Phoenix Molecular Designs Ltd is a biotechnology company based in Vancouver, Canada, with an additional office in San Diego, California. Founded in 2012, the company specializes in the development of small molecule kinase inhibitors as targeted therapies for cancer. Its primary focus is on developing first- and best-in-class inhibitors that uniquely target p90 ribosomal S6 kinase (RSK), which has shown promise in treating metastatic breast cancer, including triple-negative breast cancer (TNBC). Phoenix Molecular Designs has successfully completed a Phase 1 first-in-human clinical trial with its lead asset, PMD-026, and has also conducted a Phase 1b mono-therapy trial in TNBC across several leading medical centers in the United States. Currently, a Phase 2a trial is underway for HR+/HER2- metastatic breast cancer. The company's platform shows potential in enhancing treatment options for various refractory cancers by providing adjuncts to chemotherapy, hormone therapy, and immunotherapy.

Aspect Biosystems Ltd. is a biotechnology company based in Vancouver, Canada, specializing in 3D bioprinting and tissue engineering. Founded in 2013, the company leverages proprietary microfluidic 3D bioprinting technology to develop bioprinted tissue therapeutics aimed at transforming disease treatment. By integrating therapeutic cells and materials science, Aspect Biosystems creates allogeneic cell-based tissue therapeutics that can replace or repair damaged organ functions. The company also provides a Lab-on-a-printer technology that allows precise control over biomaterial composition and structure during tissue fabrication. Its innovative platform supports the development of novel therapeutics and enhances understanding in fundamental biology and disease research, catering to pharmaceutical firms and academic institutions focused on respiratory diseases and regenerative medicine. Aspect Biosystems is actively collaborating with researchers and industry leaders to address significant challenges in the field of regenerative medicine.

Phoenix Molecular Designs Ltd is a biotechnology company based in Vancouver, Canada, with an additional office in San Diego, California. Founded in 2012, the company specializes in the development of small molecule kinase inhibitors as targeted therapies for cancer. Its primary focus is on developing first- and best-in-class inhibitors that uniquely target p90 ribosomal S6 kinase (RSK), which has shown promise in treating metastatic breast cancer, including triple-negative breast cancer (TNBC). Phoenix Molecular Designs has successfully completed a Phase 1 first-in-human clinical trial with its lead asset, PMD-026, and has also conducted a Phase 1b mono-therapy trial in TNBC across several leading medical centers in the United States. Currently, a Phase 2a trial is underway for HR+/HER2- metastatic breast cancer. The company's platform shows potential in enhancing treatment options for various refractory cancers by providing adjuncts to chemotherapy, hormone therapy, and immunotherapy.

Damon Motors Inc. is a technology company focused on transforming urban mobility through innovative motorcycle design and safety features. Founded in 2017 and headquartered in Vancouver, Canada, with additional offices in San Rafael, California, Damon develops advanced systems aimed at enhancing rider safety and situational awareness. Its flagship product, the 360º Advanced Warning System, incorporates cutting-edge sensor fusion, robotics, and artificial intelligence to provide comprehensive environmental awareness for motorcyclists. The company’s proprietary electric powertrain, HyperDrive, powers motorcycles that boast impressive speed, distinctive design, and new features such as CoPilot and Shift. Damon Motors is committed to establishing a new benchmark for motorcycle safety and sustainability, successfully appealing to a new generation of riders in the United States and internationally.

Phoenix Molecular Designs Ltd is a biotechnology company based in Vancouver, Canada, with an additional office in San Diego, California. Founded in 2012, the company specializes in the development of small molecule kinase inhibitors as targeted therapies for cancer. Its primary focus is on developing first- and best-in-class inhibitors that uniquely target p90 ribosomal S6 kinase (RSK), which has shown promise in treating metastatic breast cancer, including triple-negative breast cancer (TNBC). Phoenix Molecular Designs has successfully completed a Phase 1 first-in-human clinical trial with its lead asset, PMD-026, and has also conducted a Phase 1b mono-therapy trial in TNBC across several leading medical centers in the United States. Currently, a Phase 2a trial is underway for HR+/HER2- metastatic breast cancer. The company's platform shows potential in enhancing treatment options for various refractory cancers by providing adjuncts to chemotherapy, hormone therapy, and immunotherapy.

Dooly Research Ltd. is a Vancouver-based company that specializes in developing artificial intelligence-driven software designed to enhance the efficiency of sales teams. Founded in 2015, Dooly's platform automates the customer relationship management process by monitoring and sharing digital notes, fields, and tasks from meetings and customer interactions. This software facilitates the seamless transfer of information between team members and systems, thereby addressing the challenges of note-taking and information sharing. By organizing workflow systems in real-time, Dooly's platform enables businesses to minimize administrative tasks, allowing sales teams to concentrate on core activities essential for closing deals.

Klue is a B2B SaaS company that specializes in market and competitive intelligence, founded in 2015 by Jason Smith and Sarathy Naicker, and is based in Vancouver, Canada. The company offers a competitive enablement platform that assists sales and revenue teams in utilizing competitive intelligence to enhance their business outcomes. Klue's platform aggregates and organizes intelligence from various internal and external sources, providing actionable insights that help organizations navigate competitive environments effectively. By leveraging this curated intelligence, businesses can make informed decisions and improve their competitive positioning in the market.

Aspect Biosystems Ltd. is a biotechnology company based in Vancouver, Canada, specializing in 3D bioprinting and tissue engineering. Founded in 2013, the company leverages proprietary microfluidic 3D bioprinting technology to develop bioprinted tissue therapeutics aimed at transforming disease treatment. By integrating therapeutic cells and materials science, Aspect Biosystems creates allogeneic cell-based tissue therapeutics that can replace or repair damaged organ functions. The company also provides a Lab-on-a-printer technology that allows precise control over biomaterial composition and structure during tissue fabrication. Its innovative platform supports the development of novel therapeutics and enhances understanding in fundamental biology and disease research, catering to pharmaceutical firms and academic institutions focused on respiratory diseases and regenerative medicine. Aspect Biosystems is actively collaborating with researchers and industry leaders to address significant challenges in the field of regenerative medicine.

Damon Motors Inc. is a technology company focused on transforming urban mobility through innovative motorcycle design and safety features. Founded in 2017 and headquartered in Vancouver, Canada, with additional offices in San Rafael, California, Damon develops advanced systems aimed at enhancing rider safety and situational awareness. Its flagship product, the 360º Advanced Warning System, incorporates cutting-edge sensor fusion, robotics, and artificial intelligence to provide comprehensive environmental awareness for motorcyclists. The company’s proprietary electric powertrain, HyperDrive, powers motorcycles that boast impressive speed, distinctive design, and new features such as CoPilot and Shift. Damon Motors is committed to establishing a new benchmark for motorcycle safety and sustainability, successfully appealing to a new generation of riders in the United States and internationally.

Routific, Inc. is a Vancouver-based company that specializes in route optimization solutions for delivery businesses. Its platform automates and enhances vehicle routing and scheduling operations, serving small and medium-sized enterprises both in Canada and internationally. Inspired by the foraging behaviors of honey bees, Routific's technology helps local delivery businesses efficiently plan routes, resulting in significant reductions in time and fuel consumption, as well as lowering carbon emissions by 20-40%. The software includes features such as intelligent route optimization, dispatch and live tracking, and delivery notifications, enabling companies to reduce delivery costs, improve driver efficiency, and enhance customer satisfaction.